$25,000 investment from Colorado Institute for Drug, Device and Diagnostic Development will advance oncology drug development
Fort Collins, CO, February 1, 2017 – Cetya Therapeutics, Inc. announced the receipt of a $25,000 investment from the Colorado Institute for Drug, Device,
and Diagnostic Development (CID4) following a competitive process. CID4 partnered with CSU Ventures to select CSU companies eligible for investment,
which were then reviewed by a CID4 panel of outside venture investors and bioscience entrepreneurs to select companies that fit best with CID4’s program.
The proceeds will be combined with additional funding to advance the company’s oncology program toward selection of a lead HDAC inhibitor compound
About Cetya Therapeutics
Cetya Therapeutics, Inc. is a Delaware C-Corporation formed in 2012 to develop histone deacetylase inhibitors based on largazole. Some of these analogs incorporate receptor ligands with the potential to target specific cell types or tumors. This is unique for HDAC inhibitors and, together with increased potency and selectivity, differentiates Cetya’s compounds. . More than 30 largazole analogs have been synthesized, some with best-in-class profiles as HDAC inhibitors. Biochemical and cell-based potency, upregulation of fetal hemoglobin expression and in-vivo anti-cancer activity have been demonstrated. Cetya is seeking corporate partners to assist in the advancement of its analog portfolio into clinical studies in a number of different therapeutic indications. For more information on Cetya, please visit our website at www.cetyatherapeutics.com.
Colorado Institute of Drug, Device and Diagnostic Development is a 501(c)(3) nonprofit corporation. CID4’s mission is to improve healthcare outcomes, reduce healthcare costs and promote the growth of the bioscience industry in Colorado by accelerating commercialization of new drugs, medical devices and diagnostics based on discoveries made at Colorado’s research institutions, with a particular focus on cancer therapeutics. For more information on CID4, please visit our website at www.cid4.com.
About CSU Ventures
CSU Ventures Inc. is a 501(c)(3) nonprofit corporation that is dedicated to the business of technology transfer and commercialization at Colorado State University, bringing innovations and technologies discovered at CSU into the marketplace for the benefit of society. For more information on CSU Ventures, please visit our website at www.csuventures.org.